22nd Century Group Inc (XXII)

[Justfactsmam]

Least ANYONE forgets, or hasn't done DD:

The company has 5-7 revenue models. (market in red)

1. Two “modified risk” cigarette candidates for F.D.A. clearance: BRAND A, a very low nicotine (VLN) cigarette and BRAND B, a very low tar-to-nicotine product (Modified Risk Products)... $80B U. S. and $700B globally. (PM study noted 90% of smokers would try MRP in attempt to cut risk from smoking...a Marketing Dream...users of product searching for yours)

2. A prescription smoking cessation aid in development (X-22)...$1.5B U. S. and $4B globally (without even addressing spin-off to Big Pharma partner...perhas PhaseI partner...Pfizer?)

3. Super premium cigarettes (Red Sun® and Magic®) …just 1% of the premium U.S. market is valued more than $1B – Lorillard (NYSE: LO) only sells cigarettes in the U.S.; has 14% market share and $15B market cap. (XXII signaled marketing and distribution already in place)

4. Huge licensing opportunities (105 patents in 78 countries and 38 patent applications) to both Big Pharma (prescription X-22) and Big Tobacco (technology and tobaccos for modified risk tobacco products...Multibillion dollar opportunity (least some forget the $14M from British American Tobacco already committed)

5. Medical Marijuana research and product development? ...using established research and resulting technologies from tobacco (since major XXII scientist already involved in MMJ research)

6. A 5-year U.S. government contract with NIDA, a department of the National Institutes of Health (NIH) to sell its SPECTRUM® research cigarettes that contain various nicotine levels (from very low to high).

7. Other Revenue Stream opportunity...published in last private Chardan Report. (not public)

New regulations could make XXII a monopoly